altRX review
altRX is a dual-modality telehealth platform offering compounded GLP-1s plus all four brand-name FDA-approved options — Mounjaro, Ozempic, Wegovy, and Zepbound — the most comprehensive brand-name lineup in…
Regulatory notice
FDA issued Trinity HealthCare Supply, LLC dba altRx a warning letter in June 2026. You can read it in FDA's warning-letter database. We still list altRX, and we may earn a commission if you start care through the link on this page.
- Scores never bought
- 537 providers tracked
- Every factor auditable
- Updated August 2026
Semaglutide here is $97/mo — $102 below our category median of $199.
- Semaglutide
- $97/mo
- Tirzepatide
- $162/mo
- Coverage
- Coverage not published
- Brand-name
- Yes
- Oral option
- Injectable only
- Verification
- LegitScript-certified
Best for: People who want the only platform offering all four brand-name GLP-1s plus compounded.
MatchScript's take: Our #115 pick of 537 — priced at or below the category median.
The factor breakdown
altRX on the six Match Score factors — the same sub-scores the quiz reweights to your priorities. See the methodology.
Semaglutide from $97/mo puts Budget Fit at a solid 82 — fair mid-market value.
Limited or undisclosed state coverage can slow your start, for a below-par 60 on Speed to Start.
altRX adds brand-name access on top of injectables, for a middling 79 on Formulary Match.
Support lands at a middling 78 — lighter, meds-first support.
Flexibility scores a below-par 55 — fewer levers to flex your plan.
LegitScript certification helps, but thin pricing and sourcing detail keeps Transparency at a below-par 72.
Pricing in context
How altRX's monthly price sits against the category median and the cheapest provider we track.
What we like
- Offers all four brand-name FDA-approved GLP-1s (Mounjaro, Ozempic, Wegovy, Zepbound) — the most comprehensive brand-name access we've reviewed
- LegitScript Certified
- Publishes the FDA compounded-medication disclaimer
- Transparent pricing across all six product tiers (compounded plus four brand-name)
- All-inclusive pricing — consult, prescription, and shipping with no hidden fees
The caveats
- States-served list not disclosed
- 503A/503B pharmacy partner not named (only 'multiple USA-certified pharmacies')
- 503A vs 503B designation not specified
- No named medical director
- FDA issued Trinity HealthCare Supply, LLC dba altRx a warning letter in June 2026; the letter is public in FDA's warning-letter database
Who it's for — and who should skip it
altRX is for people who want the only platform offering all four brand-name GLP-1s plus compounded.
Skip it if that doesn't sound like you. A closer fit may be Collective (Match Score 71) — or take the quiz to see where altRX lands for your priorities.
How it compares to CoreAge Rx & the closest scorer
altRX against our #1 overall pick and the provider that scores closest to it. Green marks the row leader.
| How it compares | altRXthis provider | CoreAge Rxour #1 | Collectiveclosest scorer |
|---|---|---|---|
| Sema price | $97/mo | $99/mo at every dose | $59/mo (medication only — a separate annual membership is required) |
| Coverage | Coverage not published | All 50 states | Coverage not published |
| Formulary | Injectable + brand | Injectable | Injectable |
| Match Score | 71 · C | 91 · A− | 71 · C |
altRX, answered
Is altRX legit?
Yes — altRX is LegitScript-certified, a third-party check that a telehealth pharmacy operates within the rules. Like most programs here it dispenses compounded GLP-1s, which are made by a licensed pharmacy but aren't FDA-approved; confirm your prescriber is US-licensed at intake.
How much does altRX cost?
altRX lists compounded semaglutide from $97/mo and tirzepatide from $162/mo — below our category median of $199/mo. These are the provider's public figures at our last review (August 2026); confirm on their site, since some teaser tiers step up after month one.
Does altRX ship to my state?
altRX doesn't publish a full state list, so confirm your state is covered during intake before you pay.
altRX vs Collective — which should I pick?
They score within a few points of each other: altRX at 71/100 and Collective at 71/100, so neither wins on the headline number. altRX is the better fit for people who want the only platform offering all four brand-name GLP-1s plus compounded. Collective suits people who will run the arithmetic on the medication charge plus the annual membership before deciding whether $59 is cheap. Run the quiz and the weighting shifts to whichever of those matters more to you.
Pricing & state data last verified August 2026 from altRX's public site and our master provider matrix. The Match Score and its sub-scores are our editorial judgment per the methodology. Commercial facts only — prices change, so confirm on altRX's site. Not medical advice; see our disclosure.
Semaglutide here is $97/mo — $102 below our category median of $199. Tirzepatide is $162/mo. Its best showing is on cost. Best suited to people who want the only platform offering all four brand-name GLP-1s plus compounded. If that is not you, Collective is the closest thing to it here.
Compare with other providers
Our next-best picks in default ranking order, then the 24 programs that sit nearest altRX here.
- #1Match91/ 100CoreAge RxThe best all-around match: nationwide access, both molecules at one flat, no-surprise price, and an easy exit.91/100
- #2Match84/ 100Strut HealthThe only program here carrying both LegitScript and ACHC accreditation, with an oral lozenge route on both molecules at the cheapest entry in this ranking.84/100
- #3Match83/ 100EdenA polished, high-disclosure compounded program with strong nationwide coverage and hands-on support.83/100
- #4Match85/ 100RoA heavyweight telehealth brand with brand-name access and a polished experience — but opaque compounded pricing.85/100
- #5Match85/ 100No BS RXThe highest Transparency score here, and it is not close: twenty-four prices on one public page and four dispensing pharmacies named with street addresses.85/100
Compare 24 nearby providersHide them
| Provider | Tirzepatide price | Coverage | Alternatives | Go | ||
|---|---|---|---|---|---|---|
| Prime Doctor RX#116 | 71 | $249 every 4 weeks | $339 every 4 weeks | Coverage not published | Alternatives | Visit |
| Synergy Rx#117 | 68 | $249/mo | $399/mo | All 50 states | Alternatives | Visit |
| Nolu#118 | 70 | $249 per 4 weeks | $336/mo | All 50 states plus Washington, D.C. | Alternatives | Visit |
| Fitness RX#119 | 70 | $192/mo | $303/mo | Coverage not published | Alternatives | Visit |
| PlexusDx#120 | 70 | $192/mo | $293/mo | All 50 states | Alternatives | Visit |
| ZYP Medical#121 | 70 | $152/mo | $236/mo | 6 states | Alternatives | Visit |
| Revel Health#122 | 70 | $202/mo | $253/mo | 45 states | Alternatives | Visit |
| Apex MD#123 | 70 | $299/mo | $399/mo | All 50 states | Alternatives | Visit |
| BiltRx#124 | 70 | $81/mo | $129/mo (all doses, compounded) | Coverage not published | Alternatives | Visit |
| Hers#125 FDA issued Hims & Hers Health, Inc. dba Hers a warning letter in September 2025. See FDA's warning-letter database. | 70 | $199/mo (starting dose, compounded) | $299/mo (starting dose, plus a separate fee, brand-name) | All 50 states | Alternatives | Visit |
| Peak Wellness#126 | 70 | $253/mo | $354/mo | All 50 states | Alternatives | Visit |
| PlushCare#127 | 70 | $149/mo (starting dose, compounded) | $399/mo (starting dose, compounded) | All 50 states | Alternatives | Visit |
| Get Thin MD#128 | 70 | $199/mo (compounded) | $299/mo (compounded) | All 50 states | Alternatives | Visit |
| RestorLife Med#129 | 70 | $303/mo | $405/mo | All 50 states | Alternatives | Visit |
| TrueMe#130 | 70 | $141/mo | $151/mo | 6 states | Alternatives | Visit |
| TeleClinic#131 | 70 | $199/mo (standing rate) | $299/mo (standing rate) | 47 states | Alternatives | Visit |
| AHBARx#132 | 70 | $249/mo (consult and shipping included) | $349/mo (consult and shipping included) | All 50 states | Alternatives | Visit |
| Longevixx#133 | 70 | $199/mo (charged every 30 days) | $299/mo (charged every 30 days) | All 50 states | Alternatives | Visit |
| SexyMD#134 | 70 | $269 per 4 weeks (the advertised headline is a 48-week commitment rate) | $369 per 4 weeks (the advertised headline is a 48-week commitment rate) | 47 states | Alternatives | Visit |
| Kin Meds#135 FDA issued Kin Meds a warning letter in February 2026. See FDA's warning-letter database. | 69 | $202/mo | $253/mo | Coverage not published | Alternatives | Visit |
| Ozari Health#136 | 69 | $178/mo | $238/mo | All 50 states | Alternatives | Visit |
| Bodi Envi#137 | 69 | $157/mo | $232/mo | Coverage not published | Alternatives | Visit |
| GobyMeds#138 | 69 | $169/mo (all doses, compounded) | $145/mo | Coverage not published | Alternatives | Visit |
| MyFastRx#139 | 69 | $139/mo | $199/mo | All 50 states | Alternatives | Visit |
altRX is ranked on our best semaglutide providers, best tirzepatide providers, best GLP-1 programs and best brand-name GLP-1 providers boards, scored on the same six factors as every other provider there.